News

PharmiWeb32m
Global Pharma Contract Commercialization Market Poised for Steady Growth Driven by Rising Demand for RWE and HEOR Services
Market is projected to grow at a CAGR of 5% through 2029, fueled by rising R&D costs, declining pharmaceutical sales, growing ...
PharmiWeb32m
Radioligand Therapy Market to Reach US$13 Billion by 2030 Driven by Cancer Prevalence and Breakthrough Clinical Trials
The global Radioligand Therapy (RLT) market is poised to reach US$13 billion by 2030, expanding at a ~5% CAGR over the ...
PharmiWeb33m
Healthcare Management Service Organization (MSO) Market Set to Grow at 12% CAGR by 2030
According to the latest report by Medi-Tech Insights titled “Global Healthcare Management Service Organization Market Size & ...
PharmiWeb31m
Timestrip Introduces New, User-Friendly Temperature Monitoring for Sensitive Supply Chains
Timestrip, the leading developer of temperature and time monitoring indicators, today announced the introduction of new ...
PharmiWeb31m
Favorable Fundings and Digital Evolution Drive GCC Countries Digital Health Market Growth to 2027
The GCC Countries Digital Health Market is poised for healthy double-digit growth by 2027, driven by favorable funding for ...
PharmiWeb32m
African Pharmaceutical Market Poised for Strong Growth: Key Opportunities for Global Pharma Companies
The African Pharmaceutical Market is projected to grow at an impressive CAGR of 6-8% by 2029, driven by a booming population, ...
PharmiWeb31m
Advancing Bone Health: European Commission Approves Biocon Biologics’ Denosumab Biosimilars
European Commission Approves Biocon Biologics’ Denosumab BiosimilarsBengaluru, Karnataka, India, July 3, 2025 Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary ...